ClearPoint Neuro, Inc. (CLPT)
Nasdaq: CLPT · Surgical & Medical Instruments & Apparatus · Solana Beach, CA · filing with the SEC since 2004
Who owns ClearPoint Neuro, Inc.
As filed with the SECHolders of 5% or more
4
Mak Capital One LLC holds 7.8% of Common Stock, $0.01 par value per share, as its SCHEDULE 13G/A filed Aug 12, 2026 says.
Directors and officers
11
report now, of 22 people on the record since 2012. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Mak Capital One LLC
SCHEDULE 13G/A · filed Aug 12, 2026 · Common Stock, $0.01 par value per share
Bigger Michael
SCHEDULE 13G/A · filed Aug 4, 2026 · Common Stock, $0.01 par value · 7.54% in Apr 20, 2026
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 27, 2026 · Common Stock · 5.6% in Jul 17, 2025
MAK Capital Fund LP
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.01 par value per share · 6.1% in Mar 13, 2026
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%, from 5.27% in Jul 29, 2025
What CLPT reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
IRRAS Holdings, Inc
A company bought · acquisition · Nov 2025 · owns, named in the 10-K filed Mar 17, 2026
7 subsidiaries in 6 countries, from the list filed with the 10-K filed Mar 17, 2026.
Insider tradesForm 4
13sales
0purchases
11sales on a scheduled plan
4people selling
$3.2Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 2, 2025 to Oct 2, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 2, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 23 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Burnett Joseph Michael | CEO and President | 10 | $2.9M | 10 | 0 | $0 |
| Klein Matthew B. | director | 1 | $200,000 | 0 | 0 | $0 |
| Richards Timothy T. | director | 1 | $100,000 | 0 | 0 | $0 |
| Fallon Lynnette C | director | 1 | $100,000 | 1 | 0 | $0 |